Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Research Council of Norway | OTHER |
| Smerud Medical Research International AS | OTHER |
| Oslo University Hospital | OTHER |
| Innovest |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The ultimate goal of treatment in early rheumatoid arthritis (RA) is remission, i.e. an absence of signs and symptoms of the disease. However, the optimal way of reaching this goal is not known.
Ultrasonography (US) is an imaging modality which application is rapidly growing. It has a number of advantages over other advanced imaging techniques such as magnetic resonance imaging (MRI), including low cost, good accessibility, and ability to scan many joints in a short period of time. However, the additional benefit of using this modality in terms of patient outcomes has not been demonstrated. Thus, clarification is needed if the use of US leads to better care for RA patients.
This study will assess if the use of a treatment strategy incorporating information from ultrasonography assessment will allow for better outcomes of patients with RA, than a strategy based on clinical and laboratory assessments alone.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Conventional clinical and laboratory assessment | No Intervention | ||
| Conventional assessment plus ultrasonography | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ultrasonography | Device | Standardized ultrasonographic assessment of 32 joints, assessed for both grey scale synovitis and power doppler signal, at each visit. Dose escalations based on DAS response in combination with change in US score. All joints with US Power Doppler signal are targets for intra articular injections. |
| Measure | Description | Time Frame |
|---|---|---|
| Complete clinical Disease Activity Score (DAS) remission | Specifically, the primary endpoint will be the proportion of patients with all the following criteria met at the end of the study (at 24 months):
| 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Magnetic Resonance Imaging (MRI) of dominant hand | MRIs of dominant hand are scored according to the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) for synovitis, bone marrow edema and erosions, and Haavardsholm tenosynovitis score, as well as a novel joint space narrowing score will be applied. | 24 months |
Not provided
Inclusion criteria (all):
Exclusion Criteria (any):
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tore K Kvien, MD, PhD | Diakonhjemmet Hospital AS | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Helse Bergen HF, Haukeland University Hospital, Dept. of Rheumatology | Bergen | Bergen | 5021 | Norway | ||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31999341 | Derived | Sundin U, Aga AB, Skare O, Nordberg LB, Uhlig T, Hammer HB, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA; ARCTIC study group. Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis. Rheumatology (Oxford). 2020 Sep 1;59(9):2550-2555. doi: 10.1093/rheumatology/kez674. | |
| 30053199 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D014463 | Ultrasonography |
| ID | Term |
|---|---|
| D003952 | Diagnostic Imaging |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
| UNKNOWN |
| Abbott | INDUSTRY |
| UCB Nordic A/S | INDUSTRY |
| Pfizer | INDUSTRY |
| MSD Norway AS | UNKNOWN |
| Roche Pharma AG | INDUSTRY |
| The Norwegian Rheumatism Association | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| American College of Rheumatology (ACR) response |
Proportion of patients with ACR20, ACR50, ACR70 and ACR90 response. |
| 24 months |
| Remission | Various definitions of remission will be calculated, including DAS-remission, ACR-remission, Simplified Diseases Activity Index (SDAI) remission and Clinical Disease Activity Index (CDAI) remission | 24 months |
| European League Against Rheumatism (EULAR) response | EULAR good, moderate and non-response | 24 months |
| Work performance |
| 24 months |
| Conventional radiography | Radiographs of hands (posterior/anterior) and foot (anterior/posterior) will be taken at baseline, 3, 6, 12, 16 and 24 months. The modified Sharp van der Heijde Score (vdHSS) will be calculated, including an erosion score and a joint space narrowing score. | 24 months |
| The RA Impact of Disease (RAID) score | The RAID includes seven domains with the following relative weights: pain (21%), functional disability (16%), fatigue (15%), emotional well-being (12%), sleep (12%), coping (12%) and physical well-being (12%). | 24 months |
| EuroQol-5 Dimension (EQ-5D) | EQ-5D is a standardised instrument for use as a measure of health outcome. | 24 months |
| Health Assessment Questionnaire (HAQ-PROMIS) | The HAQ-PROMIS is a questionnaire evaluating the physical function in patients with RA. | 24 months |
| Medical Outcomes Study Short-Form 36-item (SF-36) | The SF-36 is a multi-purpose, short-form health survey with only 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. | 24 months |
| Dual Energy X-ray Absorptiometry (DEXA) of spine and hip | Bone density measurements (DEXA hip and spine, both Z- and T-scores as well as bone mineral density) will be performed at baseline and after 12 and 24 months. | 24 months |
| Disease Activity Score (DAS) | The DAS is a composite score that includes the Ritchie articular index (RAI), the 44- swollen joint counts (SJC-44), the Erythrocyte Sedimentation Rate (ESR) and a general health (GH) assessment on a Visual Analogue Scale (VAS). The DAS is calculated as follows: DAS = 0.54*sqrt(RAI) + 0.065*(SJC-44) + 0.33*Ln(ESR) + 0.0072*GH | 24 months |
| Ultrasonography (synovitis) | 36 joints and 2 tendons will be scored for both grey scale and power doppler synovitis on a 0-3 scale. | 24 months |
| Magnetic Resonance Imaging (MRI) of dominant hand | MRIs of dominant hand are scored according to the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) for synovitis, bone marrow edema and erosions, and Haavardsholm tenosynovitis score, as well as a novel joint space narrowing score will be applied. | 12 months |
| American College of Rheumatology (ACR) response | Proportion of patients with ACR20, ACR50, ACR70 and ACR90 response. | 12 months |
| European League Against Rheumatism (EULAR) response | EULAR good, moderate and non-response | 12 months |
| Remission | Various definitions of remission will be calculated, including DAS-remission, ACR-remission, Simplified Diseases Activity Index (SDAI) remission and Clinical Disease Activity Index (CDAI) remission | 12 months |
| Work performance |
| 12 months |
| Conventional radiography | Radiographs of hands (posterior/anterior) and foot (anterior/posterior) will be taken at baseline, 3, 6 and 12 months. The modified Sharp van der Heijde Score (vdHSS) will be calculated, including an erosion score and a joint space narrowing score. | 12 months |
| The RA Impact of Disease (RAID) score | The RAID includes seven domains with the following relative weights: pain (21%), functional disability (16%), fatigue (15%), emotional well-being (12%), sleep (12%), coping (12%) and physical well-being (12%). | 12 months |
| Health Assessment Questionnaire (HAQ-PROMIS) | The HAQ-PROMIS is a questionnaire evaluating the physical function in patients with RA. | 12 months |
| Medical Outcomes Study Short-Form 36-item (SF-36) | The SF-36 is a multi-purpose, short-form health survey with only 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. | 12 months |
| Dual Energy X-ray Absorptiometry (DEXA) of spine and hip | Bone density measurements (DEXA hip and spine, both Z- and T-scores as well as bone mineral density) will be performed at baseline and after 12 and 24 months. | 12 months |
| Ultrasonography (synovitis) | 36 joints and 2 tendons will be scored for both grey scale and power doppler synovitis on a 0-3 scale. | 12 months |
| Disease Activity Score (DAS) | The DAS is a composite score that includes the Ritchie articular index (RAI), the 44- swollen joint counts (SJC-44), the Erythrocyte Sedimentation Rate (ESR) and a general health (GH) assessment on a Visual Analogue Scale (VAS). The DAS is calculated as follows: DAS = 0.54*sqrt(RAI) + 0.065*(SJC-44) + 0.33*Ln(ESR) + 0.0072*GH | 12 months |
| Martina Hansens Hospital AS |
| Sandvika |
| Bærum |
| 1306 |
| Norway |
| Vestre Viken HF, Dept. of Rheumatology | Drammen | Drammen | 3004 | Norway |
| Sykehuset Østfold HF, Dept. of Rheumatology | Moss | Fredrikstad | 1603 | Norway |
| Haugesund Sanitetsforening Revmatismesykehus | Haugesund | Haugesund | 5504 | Norway |
| Sørlandet Sykehus HF, Dept. of Rheumatology | Kristiansand | Kristiansand | 4604 | Norway |
| Diakonhjemmet Sykehus AS, Dept. of Rheumatology | Oslo | Oslo | 0319 | Norway |
| Universitetssykehuset Nord-Norge HF, Dept. of Rheumatology | Tromsø | Tromsø | 9038 | Norway |
| St Olavs Hospital HF, Dept. of Rheumatology | Trondheim | Trondheim | 7006 | Norway |
| Revmatologene bendvold/Dovland | Kristiansand | 4611 | Norway |
| Helse Sunnmøre HF, Dept. of Rheumatology | Ålesund | Ålesund | 6026 | Norway |
| Derived |
| Paulshus Sundlisaeter N, Olsen IC, Aga AB, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA; ARCTIC study group. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol. Rheumatology (Oxford). 2018 Nov 1;57(11):2022-2031. doi: 10.1093/rheumatology/key202. |
| 30001740 | Derived | Jonsson MK, Hensvold AH, Hansson M, Aga AB, Sexton J, Mathsson-Alm L, Cornillet M, Serre G, Lillegraven S, Fevang BS, Catrina AI, Haavardsholm EA. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy. Arthritis Res Ther. 2018 Jul 13;20(1):146. doi: 10.1186/s13075-018-1635-7. |
| 29934373 | Derived | Paulshus Sundlisaeter N, Aga AB, Olsen IC, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA; ARCTIC study group. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Ann Rheum Dis. 2018 Oct;77(10):1421-1425. doi: 10.1136/annrheumdis-2017-212830. Epub 2018 Jun 22. |
| 29575737 | Derived | Nordberg LB, Lillegraven S, Aga AB, Sexton J, Lie E, Hammer HB, Olsen IC, Uhlig T, van der Heijde D, Kvien TK, Haavardsholm EA. The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control Regimen. Arthritis Rheumatol. 2018 Aug;70(8):1192-1199. doi: 10.1002/art.40494. Epub 2018 Jun 29. |
| 28814431 | Derived | Jonsson MK, Sundlisaeter NP, Nordal HH, Hammer HB, Aga AB, Olsen IC, Brokstad KA, van der Heijde D, Kvien TK, Fevang BS, Lillegraven S, Haavardsholm EA. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Ann Rheum Dis. 2017 Dec;76(12):2031-2037. doi: 10.1136/annrheumdis-2017-211695. Epub 2017 Aug 16. |
| 28074154 | Derived | Aga AB, Berner Hammer H, Christoffer Olsen I, Uhlig T, Kvien TK, van der Heijde D, Fremstad H, Madland TM, Lexberg AS, Haukeland H, Rodevand E, Hoili C, Stray H, Noraas AL, Widding Hansen IJ, Bakland G, Lillegraven S, Lie E, Haavardsholm EA. Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach. RMD Open. 2016 Dec 16;2(2):e000325. doi: 10.1136/rmdopen-2016-000325. eCollection 2016. |
| 27530741 | Derived | Haavardsholm EA, Aga AB, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, Fremstad H, Madland TM, Lexberg AS, Haukeland H, Rodevand E, Hoili C, Stray H, Noraas A, Hansen IJ, Bakland G, Nordberg LB, van der Heijde D, Kvien TK. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ. 2016 Aug 16;354:i4205. doi: 10.1136/bmj.i4205. |
| 27094444 | Derived | Nordberg LB, Lillegraven S, Lie E, Aga AB, Olsen IC, Hammer HB, Uhlig T, Jonsson MK, van der Heijde D, Kvien TK, Haavardsholm EA; and the ARCTIC working group. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR/EULAR criteria. Ann Rheum Dis. 2017 Feb;76(2):341-345. doi: 10.1136/annrheumdis-2015-208873. Epub 2016 Apr 19. |
| 26085490 | Derived | Aga AB, Hammer HB, Olsen IC, Uhlig T, Kvien TK, van der Heijde D, Fremstad H, Madland TM, Lexberg AS, Haukeland H, Rodevand E, Hoili C, Stray H, Bendvold AN, Soldal DM, Bakland G, Lie E, Haavardsholm EA. First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach. Ann Rheum Dis. 2016 Aug;75(8):1444-51. doi: 10.1136/annrheumdis-2015-207572. Epub 2015 Jun 17. |
| D003240 |
| Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |